Global Paclitaxel Drug-Eluting Balloon Market Growth 2025-2031
Description
The global Paclitaxel Drug-Eluting Balloon market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Paclitaxel drug-eluting balloons are a type of medical device used in the treatment of peripheral artery disease (PAD). They are designed to deliver the drug paclitaxel to the affected area and reduce the risk of restenosis (re-narrowing of the artery).
United States market for Paclitaxel Drug-Eluting Balloon is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Paclitaxel Drug-Eluting Balloon is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Paclitaxel Drug-Eluting Balloon is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Paclitaxel Drug-Eluting Balloon players cover Medtronic, Boston Scientific, B. Braun, Cook Medical, Cardionovum, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Paclitaxel Drug-Eluting Balloon Industry Forecast” looks at past sales and reviews total world Paclitaxel Drug-Eluting Balloon sales in 2024, providing a comprehensive analysis by region and market sector of projected Paclitaxel Drug-Eluting Balloon sales for 2025 through 2031. With Paclitaxel Drug-Eluting Balloon sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Paclitaxel Drug-Eluting Balloon industry.
This Insight Report provides a comprehensive analysis of the global Paclitaxel Drug-Eluting Balloon landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Paclitaxel Drug-Eluting Balloon portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Paclitaxel Drug-Eluting Balloon market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Paclitaxel Drug-Eluting Balloon and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Paclitaxel Drug-Eluting Balloon.
This report presents a comprehensive overview, market shares, and growth opportunities of Paclitaxel Drug-Eluting Balloon market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Balloon-Only Coating
Drug-Coated Balloon
Segmentation by Application:
Peripheral Artery Disease
Coronary Artery Disease
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Medtronic
Boston Scientific
B. Braun
Cook Medical
Cardionovum
Aachen Resonance
QT Vascular
Biotronic
Philips
Eurocor
Yinyi Biotech
Lepu Medical Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Paclitaxel Drug-Eluting Balloon market?
What factors are driving Paclitaxel Drug-Eluting Balloon market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Paclitaxel Drug-Eluting Balloon market opportunities vary by end market size?
How does Paclitaxel Drug-Eluting Balloon break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Paclitaxel drug-eluting balloons are a type of medical device used in the treatment of peripheral artery disease (PAD). They are designed to deliver the drug paclitaxel to the affected area and reduce the risk of restenosis (re-narrowing of the artery).
United States market for Paclitaxel Drug-Eluting Balloon is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Paclitaxel Drug-Eluting Balloon is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Paclitaxel Drug-Eluting Balloon is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Paclitaxel Drug-Eluting Balloon players cover Medtronic, Boston Scientific, B. Braun, Cook Medical, Cardionovum, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Paclitaxel Drug-Eluting Balloon Industry Forecast” looks at past sales and reviews total world Paclitaxel Drug-Eluting Balloon sales in 2024, providing a comprehensive analysis by region and market sector of projected Paclitaxel Drug-Eluting Balloon sales for 2025 through 2031. With Paclitaxel Drug-Eluting Balloon sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Paclitaxel Drug-Eluting Balloon industry.
This Insight Report provides a comprehensive analysis of the global Paclitaxel Drug-Eluting Balloon landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Paclitaxel Drug-Eluting Balloon portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Paclitaxel Drug-Eluting Balloon market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Paclitaxel Drug-Eluting Balloon and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Paclitaxel Drug-Eluting Balloon.
This report presents a comprehensive overview, market shares, and growth opportunities of Paclitaxel Drug-Eluting Balloon market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Balloon-Only Coating
Drug-Coated Balloon
Segmentation by Application:
Peripheral Artery Disease
Coronary Artery Disease
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Medtronic
Boston Scientific
B. Braun
Cook Medical
Cardionovum
Aachen Resonance
QT Vascular
Biotronic
Philips
Eurocor
Yinyi Biotech
Lepu Medical Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Paclitaxel Drug-Eluting Balloon market?
What factors are driving Paclitaxel Drug-Eluting Balloon market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Paclitaxel Drug-Eluting Balloon market opportunities vary by end market size?
How does Paclitaxel Drug-Eluting Balloon break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
106 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Paclitaxel Drug-Eluting Balloon by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Paclitaxel Drug-Eluting Balloon by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
